Topiramate 71610-0485
Product NDC
71610-0485- Manufacturer
- Aphena Pharma Solutions - Tennessee, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 7, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA079162
Need to source Topiramate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Topiramate | 25 mg/1 |
Drug Class
Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 3A4 Inducers [MoA]Decreased Central Nervous System Disorganized Electrical Activity [PE]
Packaging Options(4)
30 TABLET in 1 BOTTLE (71610-485-30)
90 TABLET in 1 BOTTLE (71610-485-60)
120 TABLET in 1 BOTTLE (71610-485-70)
180 TABLET in 1 BOTTLE (71610-485-80)